Alphinity Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-37,302
Closed -$10.7M 33
2022
Q1
$10.7M Sell
37,302
-7,216
-16% -$1.86M 0.25% 22
2021
Q4
$12.3M Buy
44,518
+11,750
+36% +$2.98M 0.28% 24
2021
Q3
$7.57M Sell
32,768
-22,298
-40% -$5.5M 0.28% 24
2021
Q2
$12.6M Sell
55,066
-403,659
-88% -$81.1M 0.48% 22
2021
Q1
$85.7M Buy
458,725
+131,359
+40% +$25.7M 4% 17
2020
Q4
$55.3M Buy
327,366
+67,068
+26% +$10M 4.64% 9
2020
Q3
$38.5M Buy
+260,298
New +$40.3M 3.75% 18

Other funds holding LLY

Alphinity Investment Management's LLY Position: Q2 2022 in Review

Alphinity Investment Management sold out of Eli Lilly (LLY) in Q2 2022, closing a stake of 37,302 shares — an estimated $10.7M sold.

Alphinity Investment Management first reported a position in LLY in Q3 2020 and held it in 7 quarters. The position peaked at $85.7M in Q1 2021. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

  • Alphinity Investment Management reported no remaining Eli Lilly position as of Q2 2022 after selling out during the quarter.
  • Alphinity Investment Management sold 37,302 Eli Lilly shares in Q2 2022, an estimated $10.7M.
  • Alphinity Investment Management first reported a position in Eli Lilly in Q3 2020 and held it in 7 quarters.
  • Alphinity Investment Management's Eli Lilly position peaked at $85.7M in Q1 2021.
  • 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on Alphinity Investment Management's 13F filing for Q2 2022, filed 28 Jul 2022.